by Michelle | 12 Mar, 2025 | Biotech Perspectives
Back to Ideas The participation problem: addressing socioeconomic barriers in clinical trials Sponsors of late-stage clinical trials face a clear mandate from the FDA: they must assess safety and efficacy in populations that actually reflect the real world. Yet,...
by Mathieu Ranger | 3 Dec, 2024 | Biotech Perspectives
Back to Ideas Women’s representation in clinical research As a women-led company, equitable representation of women in healthcare research is especially important to us. As we strive to focus equally on women’s and men’s perspectives in our patient experience work, we...
by Mathieu Ranger | 14 Aug, 2024 | Biotech Perspectives
Back to Ideas Form design 101 Patients engaged in healthcare inevitably encounter forms — for intake, informed consent, patient support services sign-up, etc. It may feel trivial to pay attention to the experience of using and designing a form, but they’re an...
by Susan | 31 May, 2024 | Biotech Perspectives, Deconstructing Work
Back to Ideas Hybrid co-creation in pharma and biotech We did a strange thing earlier this month: we were running some co-creation workshops for a biotech client, so we flew across the continent and spent a week away from home in order to facilitate the sessions…on...
by Susan | 9 May, 2024 | Biotech Perspectives
Back to Ideas Informed consent in healthcare: adding to FDA guidance In early 2024, the Food and Drug Administration (FDA) shared a draft of Key Information and Facilitating Understanding in Informed Consent — Guidance for Sponsors, Investigators, and Institutional...
by Susan | 18 Oct, 2023 | Biotech Perspectives
Back to Ideas HCP communication best practices Pharmaceutical manufacturers spend a significant amount of time and effort designing promotional materials, programs, and services to support doctors in prescribing their products. Classic communication topics of focus...
